This page contains a Flash digital edition of a book.
• Not appropriate for post-accident or reasonable suspicion because of detection window


Positive Rate Comparison Te above pros and cons of these three specimens lead to differences in the positive rate in each specimen. When evaluating HireRight data from FY15, the medical review officer (MRO) verified positive rate is as depicted in Figure 3.


Drug Screening Program Considerations From a MRO’s perspective, there are two major categories of clients, federally regulated and non-federally regulated drug screening clients.


At face value the federally regulated clients


(oſten referred to as DOT clients since DOT regulates that vast majority of the federal programs requiring drug screening) are simpler to address. By regulation these clients have to use urine as their drug free workplace specimen; however, there is traction to adopt the other specimens (oral fluid and hair). As previously stated, SAMHSA is in the process of writing rules to incorporate oral fluid as a federal specimen and is evaluating hair as a specimen.1


Further, President Obama signed


into law the FAST Act, which compels HHS to issue guidance that permits the collection of hair as a specimen for testing.2 Non-federally regulated clients (NREG


clients) have the ability based on their specific drug free workplace programs to use specimens other than urine at their general


Employers should evaluate the various testing specimens to determine which specimen type best meets the needs of its organization.


www.datia.org


datia focus


59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80